Seed Amplification Assay as a Diagnostic Tool in Newly-Diagnosed Parkinson's Disease.

Oftedal, Linn; Maple-Grødem, Jodi; Tysnes, Ole-Bjørn; Alves, Guido; Lange, Johannes

Oftedal, Linn; Maple-Grødem, Jodi; Tysnes, Ole-Bjørn; Alves, Guido; Lange, Johannes.

Afiliação

Oftedal L; Centre for Movement Disorders, Stavanger University Hospital, Stavanger, Norway.
Maple-Grødem J; Centre for Movement Disorders, Stavanger University Hospital, Stavanger, Norway.
Tysnes OB; Department of Chemistry, Bioscience and Environmental Engineering, University of Stavanger, Stavanger, Norway.
Alves G; Department of Neurology, Haukeland University Hospital, Bergen, Norway.
Lange J; Department of Clinical Medicine, University of Bergen, Bergen, Norway.

J Parkinsons Dis ; 13(5): 841-844, 2023.

Article em En | MEDLINE | ID: mdl-37393438

Assuntos

Doença de Alzheimer; Doenças Neurodegenerativas; Doença de Parkinson; Humanos; Doença de Parkinson/diagnóstico; Doença de Parkinson/líquido cefalorraquidiano; alfa-Sinucleína/líquido cefalorraquidiano; Biomarcadores/líquido cefalorraquidiano

Palavras-chave

Parkinson's disease; Seed amplification assay; alpha-synuclein; biomarker; cerebrospinal fluid; diagnosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Doenças Neurodegenerativas / Doença de Alzheimer Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google